Ritanserin

DB12693InvestigationalSmall molecule

Ritanserin has been used in trials studying the treatment of Cocaine-Related Disorders.

Chemical structure of Ritanserin
Formula / weight
C27H25F2N3OS · 477.57 g/mol (avg)
Code names
R-55667

Resolves to

Compound
UNII145TFV465SCAS87051-43-2ChEMBLCHEMBL267777ChEBI64195PubChem5074
Structure
InChIKeyJUQLTPCYUFPYKE-UHFFFAOYSA-NSMILESCC1=C(CCN2CCC(CC2)=C(C2=CC=C(F)C=C2)C2=CC=C(F)C=C2)C(=O)N2C=CSC2=N1
Targets
Q00975CACNA1BP28335HTR2CP41595HTR2BP28223HTR2A

What you can answer from here — as of January 29, 2025

4Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
1,218Drug interactionsStructured to mechanism, not free text
Sign in
1Clinical trialPhase, status and sponsor resolved per trial
Sign in
14+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Ritanserin, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In